CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

UK/MISC/PM/0024 March 2026

Homepage / PBC HUB Webinar

PBC HUB Webinar

Wednesday, 15 July 2026 | 7:30-8:30pm

Professor Emma Culver, Consultant Hepatologist, John Radcliffe Hospital, Oxford

Dr Yiannis Kallis, Consultant Hepatologist, Royal London Hospital, London

Kath Houghton, Autoimmune Liver Nurse, Freeman Hospital, Newcastle

This promotional webinar has been developed, organised and funded by ADVANZ PHARMA and is intended for UK healthcare professionals only.

OCALIVA^®?(obeticholic acid) is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. OCALIVA^® has a conditional approval in PBC. For prescribing information, click here.

Data Processing Consent

By registering for this event, you acknowledge that ADVANZ PHARMA (the event organiser) will process your personal data (including your name, organisation, job title and registration details) for the purposes of managing your registration, administering the webinar, and sending event-related communications such as confirmation emails, reminders and updates. Your personal data will be processed in accordance with our Privacy Policy: https://www.advanzpharma.com/privacy-policy. By registering, you agree to the Terms of Registration.

Register Now

Information

2026-06-02

Adverse events should be reported. Reporting forms and information for the UK can be found at https://yellowcard.mhra.gov.uk/ and also report using the Yellow Card app. The app is available to download from the Apple App Store, or Google Play Store and you can use your Yellow Card website account details on the app to report. Adverse events should also be reported to ADVANZ PHARMA Medical Information via telephone on +44 (0) 208 588 9131 or via e-mail at medicalinformation@advanzpharma.com

Country Selector

PBC HUB Webinar

Wednesday, 15 July 2026 | 7:30-8:30pm

Register Now

Information

#{title}